Concentra Group Holdings Parent Inc

Aktienanalyse zu Concentra Group Holdings Parent Inc (CON)

$37.460

-0.079 (-0.21%)Zum Schluss

Loading chart…
Hoch
38.160
Eröffnung
37.850
Volumengewichteter Durchschnittskurs
37.64
Volumen
2.53M
Marktkap.
—
Tief
37.295
Umsatz
95.06M
EV/EBITDA, TTM
12.08

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. The Company delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care. It supports the care of approximately 54,000 patients each business day on average across 46 states and the District of Columbia at its 633 occupational health centers, 415 onsite health clinics at employer worksites, and Concentra Telemed. Its segments include Occupational health centers, Onsite health clinics, and Other businesses. Occupational health centers segment encompasses the services that it delivers at its occupational health center facilities across the United States. Onsite health clinics segment delivers occupational health services and/or employer-sponsored primary care services. The Other businesses segment comprises several complementary services, such as Concentra Pharmacy, and Concentra Medical Compliance Administration.

ir.concentra.com

KI-Analyse of Concentra Group Holdings Parent Inc (CON)

Kaufen

Concentra Group Holdings appears to be a good buy right now, with a current price of $37.19, a strong RSI of 81.207 indicating overbought conditions, and a forward P/E ratio of 18.018 suggesting reasonable valuation relative to growth expectations. The stock has shown impressive year-to-date growth of 91.60%, and analysts are optimistic about future performance, with targets suggesting potential upside of 15% to 16% from the current price. However, the main risk is the high RSI, which indicates that the stock may be overbought, and a correction could occur.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Concentra Group Holdings Parent Inc (CON) beträgt 18.02, verglichen mit dem 5-Jahres-Durchschnitt von 16.51.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
16.51
Aktuelles P/E
18.02
Überbewertet
18.90
Unterbewertet
14.11

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
11.68
Aktuelles EV/EBITDA
12.08
Überbewertet
13.25
Unterbewertet
10.11

Erwartetes KUV

Stark überbewertet
5J-Durchschnitt P/S
1.34
Aktuelles P/S
1.92
Überbewertet
1.54
Unterbewertet
1.14

Whales, die CON halten

H

HBK Investments L.P.

+ HältCON

+1.25%

3-Monats-Rendite

C

Cramer Rosenthal McGlynn LLC

+ HältCON

-6.72%

3-Monats-Rendite

Event-Zeitleiste

2026-09-14 (ET)

09:30:00

Concentra Opens New Medical Center in Florida

2026-09-08 (ET)

09:30:00

Concentra Appoints Tanner Newton as CFO

2026-07-20 (ET)

11:00:00

Concentra Opens First Medical Center in Idaho

2026-07-13 (ET)

09:31:00

Concentra Opens New Medical Center in Missouri

2026-05-07 (ET)

16:40:00

Raises FY26 Adjusted EBITDA Outlook to $460M-$480M

News

CON FAQ – beantwortet von Alphio AI

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. The Company delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care. It supports the care of approximately 54,000 patients each business day on average across 46 states and the District of Columbia at its 633 occupational health centers, 415 onsite health clinics at employer worksites, and Concentra Telemed. Its segments include Occupational health centers, Onsite health clinics, and Other businesses. Occupational health centers segment encompasses the services that it delivers at its occupational health center facilities across the United States. Onsite health clinics segment delivers occupational health services and/or employer-sponsored primary care services. The Other businesses segment comprises several complementary services, such as Concentra Pharmacy, and Concentra Medical Compliance Administration. It operates in the Healthcare sector.

Concentra Group Holdings appears to be a good buy right now, with a current price of $37.19, a strong RSI of 81.207 indicating overbought conditions, and a forward P/E ratio of 18.018 suggesting reasonable valuation relative to growth expectations. The stock has shown impressive year-to-date growth of 91.60%, and analysts are optimistic about future performance, with targets suggesting potential upside of 15% to 16% from the current price. However, the main risk is the high RSI, which indicates that the stock may be overbought, and a correction could occur.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln